Skip to main navigation
Skip to Navigation Skip to Content
Mediclinic InternationalMediclinic International

 

  • Careers
  • Contact
  • Operating Divisions
  • Results Centre
  • News
  • Operating Divisions
  • Results Centre
  • News
Search
Hirslanden Home

Header Links Bottom

  • Operating Divisions
  • Results Centre
  • News

Sidebar Links - Middle

  • About Us
  • Our Operations
  • Governance
  • Investor Relations
  • Media & News

Header Links Top

  • Careers
  • Contact
Hirslanden Home

Sidebar Right Links

About UsAbout Mediclinic InternationalStrategic OverviewPurpose, Vision and ValuesBoard of DirectorsExecutive Management
Our OperationsOperating DivisionsHirslanden - SwitzerlandMediclinic Southern AfricaMediclinic Middle East
Our InvestmentsSpire Healthcare Group - UK
GovernanceGovernance OverviewClinical ServicesCorporate GovernanceRisk ManagementSustainable DevelopmentBusiness Conduct & Ethics
Investor RelationsInvestor Overview
Share PerformanceShare ChartShare CalculatorShare Price Lookup
Results CentreResults and ReportsPresentations and Investor Days
Regulatory News
Investment Case
Investor CalendarUpcoming EventsPast Events
FinancialsFive-Year SummaryValue Added StatementAnalystsDownloads
Shareholder CentreShareholder MeetingsDividendsRegistrarsCirculars & ProspectusesCombination of Mediclinic and AI NoorShareholder Privacy
Investor ContactInvestor RelationsCompany InformationInformation RequestsEmail AlertsCompany Advisors
Media & NewsMedia CentreNews & StoriesSocial MediaMedia Kit
Careers
Investor Relations

Financial Highlights

Five-Year SummaryValue Added StatementAnalystsDownloads

Financial Highlights

Five-Year Summary

The Five-year summary is presented in pound sterling, rounded to the nearest million. Financial information of 2015 was reported in South African rand and has been translated to sterling using the procedures outlined below:

  • Assets and liabilities were translated at the closing pound rates;
  • Income and expenses were translated at average pound exchange rates; and
  • Differences resulting from re-translation have been recognised in the foreign currency translation reserve
  IFRS 16 Pre-IFRS 16
INCOME STATEMENTS FY20
£'m
FY19
£'m
FY18
£'m
FY17
£'m
FY16
£'m
Revenue 3 083 2 932 2 876 2 749 2 107
Adjusted EBITDA 541 493 515 501 428
Operating (loss)/profit (184) 81 (288) 362 288
Adjusted operating profit 327 330 370 360 335
Reported (loss)/earnings (320) (151) (492) 229 177
Adjusted earnings 177 198 221 220 219

 

PER SHARE STATISTICS FY20
pence
FY19
pence
FY18
pence
FY17
pence
FY16
pence
Basic (loss)/earnings basis (43.4) (20.5) (66.7) 31.0 29.6
Diluted (loss)/earnings basis (43.4) (20.5) (66.7) 31.0 29.5
Basic adjusted earnings basis 24.0 26.9 30.0 29.8 36.7
Diluted adjusted earnings basis 24.0 26.9 30.0 29.8 36.7
Dividends declared per share 3.20 7.90 7.90 7.90 7.90

 

STATEMENTS OF FINANCIAL POSITION FY20
£'m
FY19
£'m
FY18
£'m
FY17
£'m
FY16
£'m
ASSETS          
Non-current assets 5 741 5 337 5 382 6 353 5 604
Current assets 1 213 1 091 961 1 069 945
Total assets 6 954 6 428 6 343 7 422 6 549
 
EQUITY          
Owners of the parent 2 890 3 151 3 286 4 086 3 509
Non-controlling interest 113 115 87 78 61
Total equity 3 003 3 266 3 373 4 164 3 570
 
LIABILITIES          
Non-current liabilities 3 182 2 576 2 445 2 668 2 192
Current liabilities 769 586 525 590 787
Total liabilities 3 951 3 162 2 970 3 258 2 979
Total equity and liabilities 6 954 6 428 6 343 7 422 6 549

 

STATEMENTS OF CASH FLOWS FY20 FY19 FY18 FY17 FY16
Operating cash flow (£'m) 589 451 466 492 411
Adjusted EBITDA cash conversion (%) 109% 91% 90% 98% 96%

Email Alert Registration

Would you like to receive regular updates about Mediclinic International events and announcements? Then register for email alerts so we can send you all future updates directly.

Email Alerts

Scroll to Top
Mediclinic LogoHirslanden Home
Mediclinic International
  • About Mediclinic International
  • Our Operations
  • Governance
  • Investor Relations
  • Media & News
  • Careers
Contact
© Mediclinic International
Modern Slavery Statement
Terms of Use
Privacy Statement

The website uses cookies to provide necessary site functionality and improve your online experience. By using this website, you agree to the use of cookies as outlined in our recently updated Privacy Notice.